High-potency Class I to II topicals are frequently used first line to suppress inflammation and symptoms of itching. These agents are often useful as therapy for stage IA disease, but are often ...

WAUSAU, Wis. (WSAW) - As they say, April showers bring May flowers. But before we get to blooming flowers, those rain showers and standing water make one disease more common this time of year ...

Tecovirimat is available for the treatment of mpox (formerly known as monkeypox) in Europe and the United States, on the basis of findings from efficacy studies in animals and safety evaluations ...

Prescient Therapeutics (ASX: PTX) has received fast-track designation from the US Food and Drug Administration for lead candidate PTX-100 to treat adults with relapsed or refractory mycosis fungoides.

1 The investigator-initiated, open-label, multicenter trial is evaluating the real-world application of SGX301 in approximately 20 patients with mycosis fungoides, the most common type of CTCL.

The following is a summary of “ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome,” published in the April 2025 issue of ...

Having been first diagnosed with a rare form of cancer called mycosis fungoides at the age of 28 he eventually died of the illness at the age of 68 in 1995. He and Patricia, his wife of 43 years ...